Process for the preparation of efavirenz
Abstract
A process for the preparation of Efavirenz, (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, of formula (I): comprising reacting the intermediate of formula (II): as a free base or a salt thereof, with diphosgene (TCMCF, trichloromethylchloroformate) Cl 3 CO—COCl in an organic solvent or in a biphasic medium comprised of an organic solvent and water, preferably but not mandatorily in the presence of a weak base in an amount sufficient to neutralize the reaction mixture or in an up to 30% molar excess of such amount.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . Intermediate of formula (II)
comprising p-chloroaniline in no more than 200 ppm amount, as determined by HPLC.
2 . Efavirenz of formula (I)
containing no more than 10 ppm of p-chloroaniline as determined by HPLC.Join the waitlist — get patent alerts
Track US2013165650A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.